AReUReDi: Annealed Rectified Updates for Refining Discrete Flows with Multi-Objective Guidance
Tong Chen, Yinuo Zhang, Pranam Chatterjee
TL;DR
AReUReDi tackles discrete multi-objective biomolecule design by extending Rectified Discrete Flows with annealed Chebyshev scalarization, locally balanced proposals, and Metropolis-Hastings updates to guarantee convergence to the Pareto front while preserving distributional invariance. The framework defines $S_{\omega}(x) = \min_{1\le n\le N} \omega_n \tilde{s}_n(x)$ and $W_{\eta_t,\omega}(x) = \exp(\eta_t S_{\omega}(x))$, employing an annealing schedule on $\eta_t$ and reversible, coordinate-wise proposals to navigate trade-offs across up to five objectives in peptide and SMILES design. Theoretical results include invariance of the sampling kernel and full-coverage convergence to Pareto-optimal states, with empirical demonstrations showing superior Pareto front navigation and biologically plausible, diverse sequences compared to traditional MOO methods and diffusion baselines. The approach delivers a principled, scalable tool for multi-property biomolecule generation, enabling simultaneous optimization of potency, stability, solubility, and safety across amino-acid sequences and chemically modified peptide backbones.
Abstract
Designing sequences that satisfy multiple, often conflicting, objectives is a central challenge in therapeutic and biomolecular engineering. Existing generative frameworks largely operate in continuous spaces with single-objective guidance, while discrete approaches lack guarantees for multi-objective Pareto optimality. We introduce AReUReDi (Annealed Rectified Updates for Refining Discrete Flows), a discrete optimization algorithm with theoretical guarantees of convergence to the Pareto front. Building on Rectified Discrete Flows (ReDi), AReUReDi combines Tchebycheff scalarization, locally balanced proposals, and annealed Metropolis-Hastings updates to bias sampling toward Pareto-optimal states while preserving distributional invariance. Applied to peptide and SMILES sequence design, AReUReDi simultaneously optimizes up to five therapeutic properties (including affinity, solubility, hemolysis, half-life, and non-fouling) and outperforms both evolutionary and diffusion-based baselines. These results establish AReUReDi as a powerful, sequence-based framework for multi-property biomolecule generation.
